Papers
1
Total Citations
173
H-Index
1
About
Dr. ID Kerr is a leading researcher in neglected tropical diseases, with a primary focus on Chagas disease drug discovery. His most impactful work, the highly cited 2009 review "Two approaches to discovering and developing new drugs for Chagas disease" (173 citations), provides a foundational framework for the field. In this seminal paper, Dr. Kerr outlines two complementary strategies employed at the Sandler Center, UCSF: target-based drug discovery—exemplified by work on cytochrome P450 enzymes—and phenotypic screening. His major contribution lies in systematically bridging these approaches to overcome the unique challenges of developing treatments for *Trypanosoma cruzi* infection. By clearly articulating the rationale, strengths, and pitfalls of each method, his work has guided subsequent research efforts and shaped the strategic thinking of a generation of medicinal chemists and parasitologists. Dr. Kerr’s research continues to be instrumental in advancing the pipeline of potential therapeutics for this devastating disease, which affects millions across Latin America.
Research Focus
Key Achievements
Top Papers
- 1Two approaches to discovering and developing new drugs for Chagas disease173 citations · 2009